OpenEvidence Raises $210M Series B at $3.5B Valuation as Medical AI Platform Serves 40% of U.S. Physicians
OpenEvidence secures $210M Series B funding at $3.5B valuation as its medical AI platform now serves over 40% of U.S. physicians daily across 10,000+ hospitals, handling 8.5 million clinical consultations monthly while launching DeepConsult™, the first AI agent designed specifically for autonomous medical research.